News in the Life Sciences Industry

SUZHOU and SHANGHAI, China, Feb. 25, 2019 /PRNewswire/ -- Gracell Biotechnologies, Co., Ltd. ("Gracell") announced the completion of its $85 million series B funding today. The financing was led by Temasek with Lilly Asia Ventures, Kington Capital, King Star Capital and Chengdu Miaoji also participating... Read more ››

ABBOTT PARK, Ill., Feb. 25, 2019 /PRNewswire/ -- Abbott (NYSE: ABT) will present at the Barclays Global Healthcare Conference on Wednesday, March 13, 2019. Brian Yoor, executive vice president of finance and chief financial officer, will present at 1:05 p.m. Central time.

TOKYO and MUNICH and BASKING RIDGE, N.J., Feb. 22, 2019 /PRNewswire/ -- Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced senior-level organizational changes to oversee the realization of the company's long-term vision and strategic priorities, which include delivering... Read more ››

ABBOTT PARK, Ill., Feb. 22, 2019 /PRNewswire/ -- The board of directors of Abbott (NYSE: ABT) today declared a quarterly common dividend of 32 cents per share.

- Data presented at ATTD confirms previous analyses that higher rates of scanning with the FreeStyle Libre system are strongly associated with improved glucose control

GOTHENBURG, Sweden and ZUG, Switzerland, Feb. 21, 2019 /PRNewswire/ -- POA Pharma Scandinavia AB, a market-oriented Boutique Healthcare Company, working in close contact with healthcare organizations, professionals and hospitals in Nordic countries and Primex Pharmaceuticals AG, an innovative... Read more ››

ABBOTT PARK, Ill., Feb. 20, 2019 /PRNewswire/ -- Abbott (NYSE: ABT) announced today it has received CE Mark for the world's most sensitive rapid diagnostic test for the detection of hepatitis B surface antigen, the Read more ››

ABBOTT PARK, Ill. and BAGSVÆRD, Denmark, Feb. 20, 2019 /PRNewswire/ -- Abbott (NYSE: ABT) and Novo Nordisk today announced a non-exclusive partnership that will integrate insulin dose data from Novo Nordisk pre-filled and durable connected pens directly into the digital health tools compatible... Read more ››

LYON, France, Feb. 20, 2019 /PRNewswire/ --

- Proxy-CRISPR technology provides solution to improve genome editing and advance new possibilities for research

PARIS, February 18, 2019 /PRNewswire/ --

Not intended for US, Canada and UK-based media